X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
DR. REDDY'S LABORATORIES LIMITED Quarterly Results - Equitymaster
 
DR. REDDY'S LABORATORIES LIMITED   - Last 8 Quarters  (REDY)

Here are the latest quarterly results of Dr. Reddys. For more details, see the Dr. Reddys financial fact sheet and Dr. Reddys share price and chart. For a sector overview, read our pharmaceuticals sector report.
 Interim Results
No. of Months
Qtr. Ending
3
Mar-15
*
3
Jun-15
*
3
Sep-15
*
3
Dec-15
*
3
Mar-16
*
3
Jun-16
*
3
Sep-16
*
3
Dec-16
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m38,70437,57839,89039,67937,56232,22536,16337,232 
Other income Rs m125125320122307670438403 
Turnover Rs m38,83037,70340,21039,80137,86932,89536,60137,635 
Expenses Rs m32,71038,03630,95232,22332,79728,32329,89328,587 
Gross profit Rs m5,9947,4628,6187,5844,8243,9756,3558,734 
Depreciation Rs m000002,4362,6222,665 
Interest Rs m233-216216622,646148126164 
Profit before tax Rs m5,8877,8038,7227,6442,4852,0614,0456,308 
Tax Rs m7421,7211,8791,7881,7395269561,385 
Profit after tax Rs m5,1456,0826,8435,8567461,5353,0894,923 
Gross profit margin %15.519.921.619.112.812.317.623.5 
Effective tax rate %12.622.121.523.470.025.523.622.0 
Net profit margin %13.316.217.214.82.04.88.513.2 
Diluted EPS Rs 31.0 36.7 41.3 35.3 4.5 9.3 18.6 29.7  
Diluted EPS (TTM) Rs 133.3 136.8 143.7 144.4 117.8 90.4 67.7 62.1  
 Subscriber Feature Our View Our View Our View     Our View      
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster



Today's Market

Global Financial Markets Remain Cautious(RoundUp)

Most of the global financial markets ended the week on a negative note. Major global markets were cautious over the week over concerns of the Trump administration's ability to push out reforms.

Views on news

Dr Reddy's: Major Business Segments Come Under Pressure (Quarterly Results Update - Detailed)

Sep 12, 2016

Dr Reddy's has announced the results for first quarter of FY17 (1QFY17). The company has reported decline in the sales by 13.9% YoY while net profits declined by 79.8 % YoY.

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

More Views on News

Most Popular

Bluechips Have 60% Chance Of Losing Money At Current Levels. But a Small Group Won't...(The 5 Minute Wrapup)

Mar 17, 2017

The trend that makes a select group of bluechip stocks inherently safer even at peak index valuations.

As Digital Transactions Fall, Indians Are Going Back to Cash(Vivek Kaul's Diary)

Mar 16, 2017

Digital transactions have fallen since December 2016 both in value and volume terms.

Doubled Your Money In D-Mart? Read This Before It's Too Late(Daily Profit Hunter)

Mar 22, 2017

Apurva breaks down the historic performance of initial public offerings in the context of D-Mart.

Stock Markets and Gold Rally, Dollar Tumbles(Chart Of The Day)

Mar 16, 2017

Markets are moving up even after the fed interest rate hike.

Why Mutual Fund Investors Should Not Worry About Market High. But...(Outside View)

Mar 22, 2017

PersonalFN provides a prudent investment strategy to invest in mutual funds as market scales a new high.

More

DR. REDDYS LAB SHARE PRICE


Mar 24, 2017 (Close)

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB 5-YR ANALYSIS

Detailed Financial Information With Charts

COMPARE DR. REDDYS LAB WITH

MARKET STATS